| http://www.w3.org/ns/prov#value | - Beyond continued geographic expansions to markets such as Russia, Brazil, Mexico, China and South Korea, opportunities to better define the emerging role of REVLIMID for the treatment of lymphoma and leukemia should come into focus later this year.
|
